What We Heard on AI in Pharma

Aiddd

What We Heard on AI in Pharma BioTeam’s Michelle Bayly, Wisdom Akpan, and Jennifer Wortman attended the AI Drug Discovery and Development Summit (AIDDD 2026) from October 27 to 29 in Boston. One theme came up on stage and in the hallways more than any other: nobody has yet figured out how to integrate AI […]

Ask the Archive

Screenshot 2026 10 28 At 1.25.30 pm

Someone on your team needs an answer your organization already has. It sits in a report from a past project, a slide deck on a former colleague’s laptop, or a folder in someone’s personal drive. After enough searching, they give up and start from scratch. BioTeam was in the same position. Our domain knowledge lived […]

7 Signs It’s Time to Hire a Scientific IT Consulting Firm

Chatgpt Image Jul 21, 2026, 06 32 48 Pm

Knowing when to bring in outside expertise can determine whether your next scientific IT initiative succeeds or stalls. Here are seven common signs that your organization could benefit from a specialized scientific IT consulting partner. Scientific organizations are under increasing pressure to modernize research infrastructure, prepare for AI, manage rapidly growing datasets, and accelerate discovery. […]

AI in Life Sciences: Frequently Asked Questions

Chatgpt Image Jul 20, 2026, 04 16 00 Pm

Artificial intelligence is transforming life sciences, but many organizations are asking the same questions as they begin their AI journey. How do you prepare your data? Do you need GPUs? What does “AI-ready” actually mean? This FAQ answers some of the most common questions BioTeam hears from pharmaceutical companies, biotechnology organizations, academic medical centers, and […]

Beyond GPUs: What Does It Mean to Be AI Ready?

Screenshot 2026 06 30 At 5.29.57 pm

Artificial intelligence is rapidly changing the way life sciences organizations approach research, from protein structure prediction and antibody design to multiomics analysis and scientific data interpretation. But despite the excitement surrounding generative AI and machine learning, many organizations are still asking a more fundamental question: What does it actually mean to be AI-ready? The answer […]

Bio-IT World’s Trends from the Trenches Podcast: Reducing Data Friction for AI and HPC in Life Sciences

Trends Episode042 1200x628

Life sciences organizations are generating more data than ever before, but many research environments still struggle with fragmented infrastructure, disconnected workflows, and data spread across storage systems, sites, and clouds. In this episode of Bio-IT World’s Trends from the Trenches podcast, Adam Marko, Field CTO for Life Sciences at Hammerspace, joins BioTeam’s Jessica StLouis to […]

Where to Find BioTeam at Bio-IT World 2026

Screenshot 2026 05 12 At 1.58.10 pm

Bio-IT World is almost here, and BioTeam will be participating across workshops, technical sessions, track leadership, networking events, and podcast conversations throughout the week in Boston.This year, many of the conversations we are having with research organizations, platform teams, and infrastructure leaders center around reproducible AI workflows, scientific data operations, cloud/HPC modernization, and preparing research […]

Agentic Biotech Is Coming Fast. Most Systems Aren’t Ready.

Agentic Biotech Is Coming Fast. Most Systems Arent Ready. Aws Life Sciences Symposium 300x300

The life sciences industry has spent the last several years getting excited about AI. Now it’s getting specific. Jennifer Wortman, Nick George, Brian Osborne, and Abby Farrar were in New York last week at the AWS Life Sciences Symposium. The conversation had moved on from “should we use AI?” to something harder: how do you […]

The Data Layer Problem Life Sciences Can’t Ignore

Screenshot 2026 04 13 At 12.50.38 pm

    The Data Layer Problem Life Sciences Can’t Ignore Applications have gone serverless, stateless, and intelligent. But across much of the life sciences industry, the data infrastructure underneath them hasn’t kept pace. Legacy databases remain monolithic, expensive to maintain, and painful to migrate. That disconnect is becoming harder to ignore as organizations push toward […]

AI Drug Discovery Panel Features BioTeam’s Managing Director Jennifer Wortman

Case Study Implementing Healthomics For Cancer Diagnostics

  At the recent DataFair Boston workshop, BioTeam’s Managing Director, Jennifer Wortman, participated in a panel discussion focused on a growing tension within the biomedical research community. The discussion explored the relationship between the expanding availability of large public datasets and the continued need for context-rich data to support meaningful drug discovery. Panelists discussed the […]